Sale!

HLA – Panel Reactive IgG Antibodies PRA Screen Test Cost

Original price was: 1,510 د.إ.Current price is: 1,360 د.إ.

-10%

The HLA – Panel Reactive IgG Antibodies PRA Screen Test is a crucial diagnostic tool used to assess the level of sensitization of a patient’s immune system to Human Leukocyte Antigen (HLA) mismatches. This test is particularly significant in the context of organ transplantation, as it helps to predict the potential for transplant rejection by identifying the presence of pre-formed antibodies against HLA in a patient’s blood. A high percentage of panel-reactive antibodies (PRA) indicates a higher risk of graft rejection, making this test an essential step in the pre-transplant evaluation process.

Conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive range of diagnostic services, the HLA – Panel Reactive IgG Antibodies PRA Screen Test is priced at 1360 AED. The lab employs advanced methodologies and technology to ensure accurate and reliable results, aiding in the effective management and treatment planning for patients awaiting organ transplantation. This test is a critical component of the organ matching process, helping to increase the success rate of transplants by ensuring compatibility between donor and recipient.

Description

HLA – PANEL REACTIVE IgG ANTIBODIES PRA SCREEN Test

Test Name: HLA – PANEL REACTIVE IgG ANTIBODIES PRA SCREEN Test

Components: Class I, Class II

Price: 1360.0 AED

Sample Condition: 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Collect specimen preferably 48 hours after dialysis. Provide brief clinical history.

Report Delivery: 10-12 days

Method: Luminex X-Map technology

Test type: Transplantation

Doctor: Nephrologist, Gastroenterologist, Hematologist

Test Department:

Pre Test Information: Collect specimen preferably 48 hours after dialysis. Provide brief clinical history.

Test Details:

The HLA – Panel Reactive IgG Antibodies (PRA) screen test is a laboratory test that is used to determine the presence of antibodies in a person’s blood against human leukocyte antigens (HLA). HLA antigens are proteins found on the surface of cells that play a crucial role in immune responses.

The PRA screen test is typically performed before organ transplantation, such as kidney or heart transplant, to assess the compatibility between the donor and recipient. It helps identify the presence of pre-formed antibodies in the recipient’s blood that could potentially cause rejection of the transplanted organ.

During the test, the recipient’s blood sample is mixed with a panel of cells that express different HLA antigens. If the recipient has antibodies against any of these HLA antigens, the antibodies will bind to the corresponding cells in the panel. The binding is then detected using various techniques, such as flow cytometry or enzyme-linked immunosorbent assay (ELISA).

The results of the PRA screen test are reported as a percentage, known as the panel reactive antibody (PRA) level. A higher PRA level indicates a greater likelihood of antibody-mediated rejection and may pose challenges in finding a suitable organ donor.

The PRA screen test is an important tool in the evaluation of transplant candidates and helps guide the selection of compatible donors. It provides valuable information to transplant teams to minimize the risk of rejection and improve the success of organ transplantation.

Test Name	HLA – PANEL REACTIVE IgG ANTIBODIES PRA SCREEN Test
Components	Class IClass II
Price	1360.0 AED
Sample Condition	3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Collect specimen preferably 48 hours after dialysis. Provide brief clinical history.
Report Delivery	10-12 days
Method	Luminex X-Map technology
Test type	Transplantation
Doctor	Nephrologist, Gastroenterologist, Hematologist
Test Department:
Pre Test Information	Collect specimen preferably 48 hours after dialysis. Provide brief clinical history.
Test Details	The HLA – Panel Reactive IgG Antibodies (PRA) screen test is a laboratory test that is used to determine the presence of antibodies in a person’s blood against human leukocyte antigens (HLA). HLA antigens are proteins found on the surface of cells that play a crucial role in immune responses. The PRA screen test is typically performed before organ transplantation, such as kidney or heart transplant, to assess the compatibility between the donor and recipient. It helps identify the presence of pre-formed antibodies in the recipient’s blood that could potentially cause rejection of the transplanted organ. During the test, the recipient’s blood sample is mixed with a panel of cells that express different HLA antigens. If the recipient has antibodies against any of these HLA antigens, the antibodies will bind to the corresponding cells in the panel. The binding is then detected using various techniques, such as flow cytometry or enzyme-linked immunosorbent assay (ELISA). The results of the PRA screen test are reported as a percentage, known as the panel reactive antibody (PRA) level. A higher PRA level indicates a greater likelihood of antibody-mediated rejection and may pose challenges in finding a suitable organ donor. The PRA screen test is an important tool in the evaluation of transplant candidates and helps guide the selection of compatible donors. It provides valuable information to transplant teams to minimize the risk of rejection and improve the success of organ transplantation.